Parnasa Mediworld

Supply of pharmaceutical medicines in India.

About Parnasa Mediworld

Parnasa Mediworld is a Healthcare company. Supply of pharmaceutical medicines in India. The company has 25 employees. Its Indian entity Parnasa Mediworld Private Limited reported revenue of β‚Ή12.86 Cr. Parnasa Mediworld offers products and services including Bonabond Capsules and CobiMax Capsules. Its focus areas include Pharmaceuticals, Related Products, Powders and Sachets and Medicine Supply.

Company details

Parnasa Mediworld Private Limited is recognized as a supplier of pharmaceutical medicines in the Indian market, with a variety of products such as Bonabond Capsules, CobiMax Capsules, and Collpure Tablets being made available. The company, which was established in 2016 in Delhi, India, operates under the direction of its professionals to ensure that premium lots reach buyers. These medicines are noted for their effectiveness, purity, and hygienic preparation, supporting market needs without promotional emphasis. A group of experts is involved in maintaining quality standards.

  • Employees 25
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website parnasamediworld.in
  • Social X Facebook
  • Legal Name Parnasa Mediworld Private Limited
  • Date of Incorporation 17 Mar, 2016
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Indian entity revenue
    ₹12.86 Cr

    FY 2025 · +3% YoY

  • Indian entity net profit
    ₹17.9 Lakh

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹87.6 Lakh

    FY 2025 · 7% margin

  • Employee Count
    25

Products & Services of Parnasa Mediworld

Parnasa Mediworld offers a comprehensive portfolio of products and services, including Bonabond Capsules and CobiMax Capsules.

Bonabond Capsules
Pharmaceutical Medicines

Capsules that contain calcium citrate and are utilized for health-related purposes

CobiMax Capsules
Pharmaceutical Medicines

Capsules that contain Omega-3 and are provided for medicinal applications

Board of directors of Parnasa Mediworld Private Limited (Parnasa Mediworld)

Parnasa Mediworld Private Limited is the primary company behind Parnasa Mediworld. The board of Parnasa Mediworld Private Limited currently have 2 directors; the longest-serving is Keshri Kant Mishra, appointed in 2016. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Keshri Kant Mishra
DIN 07471294
Director17 Mar 201610 yrs 8 moParnasa Mediworld Private Limited
Kanak Kant Mishra
DIN 07474096
Director17 Mar 201610 yrs 8 moParnasa Mediworld Private Limited

Financials of Parnasa Mediworld

Figures of Parnasa Mediworld Private Limited, the primary company behind Parnasa Mediworld, for FY 2025. Revenue was ₹12.86 Cr (+3% year on year). Net profit was ₹17.9 Lakh (1% margin). EBITDA was ₹87.6 Lakh (7% margin). Revenue has grown at a compounded annual rate of +30% over three years and +13% over five years.

  • ₹12.86 CrRevenue · FY 2025 · +3% YoY
  • ₹17.9 LakhNet profit · 1% margin
  • ₹87.6 LakhEBITDA · 7% margin
  • ₹5 LakhPaid-up capital
  • 25Employees (provident fund records)
  • +30%Revenue CAGR, 3 years
  • +13%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Parnasa Mediworld Private Limited are on its company page.

Premium access

Detailed financial statements for Parnasa Mediworld

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Parnasa Mediworld

Parnasa Mediworld has 25 employees.

The primary company behind Parnasa Mediworld, Parnasa Mediworld Private Limited, reported revenue of β‚Ή12.86 Cr for FY 2025, up 3% year on year.

Parnasa Mediworld Private Limited is recognized as a supplier of pharmaceutical medicines in the Indian market, with a variety of products such as Bonabond Capsules, CobiMax Capsules, and Collpure Tablets being made available. The company, which was established in 2016 in Delhi, India, operates under the direction of its professionals to ensure that premium lots reach buyers. These medicines are noted for their effectiveness, purity, and hygienic preparation, supporting market needs without promotional emphasis. A group of experts is involved in maintaining quality standards.

Parnasa Mediworld offers Bonabond Capsules and CobiMax Capsules.

Parnasa Mediworld operates through Parnasa Mediworld Private Limited.

The legal entities of Parnasa Mediworld currently have 2 directors, including Keshri Kant Mishra, Kanak Kant Mishra.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available